These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38697162)

  • 1. Evaluating cancer care in low-income and middle-income countries.
    Pari V; Tirupakuzhi Vijayaraghavan BK; Biccard BM; Hashmi M
    Lancet Oncol; 2024 May; 25(5):e179. PubMed ID: 38697162
    [No Abstract]   [Full Text] [Related]  

  • 2. The global cancer epidemic: opportunities for Canada in low- and middle-income countries.
    Ginsburg OM; Hanna TP; Vandenberg T; Joy AA; Clemons M; Game M; Maccormick R; Elit LM; Rosen B; Rahim Y; Geddie W; Sutcliffe SB; Gospodarowicz M
    CMAJ; 2012 Oct; 184(15):1699-704. PubMed ID: 22496379
    [No Abstract]   [Full Text] [Related]  

  • 3. Expansion of cancer care and control in countries of low and middle income: a call to action.
    Farmer P; Frenk J; Knaul FM; Shulman LN; Alleyne G; Armstrong L; Atun R; Blayney D; Chen L; Feachem R; Gospodarowicz M; Gralow J; Gupta S; Langer A; Lob-Levyt J; Neal C; Mbewu A; Mired D; Piot P; Reddy KS; Sachs JD; Sarhan M; Seffrin JR
    Lancet; 2010 Oct; 376(9747):1186-93. PubMed ID: 20709386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priorities for cancer research in low- and middle-income countries: a global perspective.
    Pramesh CS; Badwe RA; Bhoo-Pathy N; Booth CM; Chinnaswamy G; Dare AJ; de Andrade VP; Hunter DJ; Gopal S; Gospodarowicz M; Gunasekera S; Ilbawi A; Kapambwe S; Kingham P; Kutluk T; Lamichhane N; Mutebi M; Orem J; Parham G; Ranganathan P; Sengar M; Sullivan R; Swaminathan S; Tannock IF; Tomar V; Vanderpuye V; Varghese C; Weiderpass E
    Nat Med; 2022 Apr; 28(4):649-657. PubMed ID: 35440716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy and priorities for national cancer control planning in low- and middle-income countries: Lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study.
    ACTION Study Group
    Eur J Cancer; 2017 Mar; 74():26-37. PubMed ID: 28335885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Cancer Clinical Trials-Cooperation Between Investigators in High-Income Countries and Low- and Middle-Income Countries.
    Panda PK; Jalali R
    JAMA Oncol; 2018 Jun; 4(6):765-766. PubMed ID: 29566116
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges to Cancer Program Development in Low- and Middle-Income Countries.
    Beddoe AM; Nair N; Dottino P
    Ann Glob Health; 2016; 82(4):614-620. PubMed ID: 27986228
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer control opportunities in low- and middle-income countries.
    Huerta E; Grey N
    CA Cancer J Clin; 2007; 57(2):72-4. PubMed ID: 17392384
    [No Abstract]   [Full Text] [Related]  

  • 9. Global health from a cancer care perspective.
    Pesec M; Sherertz T
    Future Oncol; 2015; 11(15):2235-45. PubMed ID: 26235185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the development of health insurance in low-income countries: the case of African countries].
    Letourmy A
    C R Biol; 2008 Dec; 331(12):952-63. PubMed ID: 19027696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The barriers to initiating lung cancer care in low-and middle-income countries.
    Lubuzo B; Ginindza T; Hlongwana K
    Pan Afr Med J; 2020; 35():38. PubMed ID: 32499854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Development in Low- and Middle-Income Countries: Opportunity or Exploitation?
    Jalali R; Nogueira-Rodrigues A; Das A; Sirohi B; Panda PK
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-8. PubMed ID: 35658520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar.
    Selmouni F; Zidouh A; Belakhel L; Sauvaget C; Bennani M; Khazraji YC; Benider A; Wild CP; Bekkali R; Fadhil I; Sankaranarayanan R
    Lancet Oncol; 2018 Feb; 19(2):e93-e101. PubMed ID: 29413484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health equity: challenges in low income countries.
    Orach CG
    Afr Health Sci; 2009 Oct; 9 Suppl 2(Suppl 2):S49-51. PubMed ID: 20589106
    [No Abstract]   [Full Text] [Related]  

  • 15. The burden of musculoskeletal injury in low and middle-income countries: challenges and opportunities.
    Spiegel DA; Gosselin RA; Coughlin RR; Joshipura M; Browner BD; Dormans JP
    J Bone Joint Surg Am; 2008 Apr; 90(4):915-23. PubMed ID: 18381331
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hazards, tactics and constraints of evaluation of health care in low income countries].
    Audibert M
    C R Biol; 2008 Dec; 331(12):1007-15. PubMed ID: 19027702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer care cost-effectiveness in low-income and middle-income countries: time to shift the burden of proof.
    Painschab MS
    Lancet Glob Health; 2022 Aug; 10(8):e1084-e1085. PubMed ID: 35839803
    [No Abstract]   [Full Text] [Related]  

  • 18. Heartbeat: Implementation gaps in cardiovascular care in middle-low income countries.
    Ribeiro AL; Otto CM
    Heart; 2017 Dec; 103(23):1837-1839. PubMed ID: 29142000
    [No Abstract]   [Full Text] [Related]  

  • 19. Integration of HIV and noncommunicable diseases in health care delivery in low- and middle-income countries.
    Nigatu T
    Prev Chronic Dis; 2012; 9():E93. PubMed ID: 22554408
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating and Improving Cardiovascular Health System Management in Low- and Middle-Income Countries.
    Yoo SGK; Prabhakaran D; Huffman MD
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29133473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.